Colorectal Cancer (CRC) Unknown Status Phase Trials for Oxaliplatin (DB00526)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Unknown Status	Not Available

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05873972	Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05978349	PTC Drug Sensitivity Detection to Guide Postoperative Adjuvant of Colorectal Cancer	Treatment	Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Oxaliplatin (DB00526)
NCT05544812	A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer		Bevacizumab (DB00112) Capecitabine (DB01101) Cetuximab (DB00002) Oxaliplatin (DB00526) Sintilimab (DB15765)
NCT05832398	Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT03668418	Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos		Camptothecin (DB04690) Cisplatin (DB00515) Docetaxel (DB01248) Epirubicin (DB00445) Fluorouracil (DB00544) Gemcitabine (DB00441) Irinotecan (DB00762) Levoleucovorin (DB11596) Oxaliplatin (DB00526) Paclitaxel (DB01229) Platinum (DB12257)